Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul J Gilligan

Showing results (1-10 of 23) with videos related to

Pageof 3
Sort By:
Expert Opinion on Therapeutic Patents|February 11, 2010
Corticotropin-releasing factor receptor antagonistsPaul J Gilligan
Current Topics in Medicinal Chemistry|April 3, 2015
Inhibitors of leucine-rich repeat kinase 2 (LRRK2): progress and promise for the treatment of Parkinson's diseasePaul J Gilligan
Current Opinion in Drug Discovery & Development|September 2, 2004
Corticotropin-releasing factor antagonists: recent advances and exciting prospects for the treatment of human diseasesPaul J Gilligan, Yu-Wen Li
Psychopharmacology|March 15, 2005
Effects of CRF1 receptor antagonists and benzodiazepines in the Morris water maze and delayed non-matching to position testsJohn B Hogan, Donald B Hodges, Snjezana Lelas, et al.
Bioorganic & Medicinal Chemistry Letters|January 30, 2002
Synthesis and evaluation of imidazo[1,5-a]pyrazines as corticotropin releasing hormone receptor ligandsRichard A Hartz, Paul J Gilligan, Kausik K Nanda, et al.
Psychopharmacology|December 11, 2002
The CRF(1) receptor antagonist DMP696 produces anxiolytic effects and inhibits the stress-induced hypothalamic-pituitary-adrenal axis activation without sedation or ataxia in ratsJohn F McElroy, Kathryn A Ward, Kim L Zeller, et al.
Bioorganic & Medicinal Chemistry Letters|December 17, 2002
CRF ligands via Suzuki and Negishi couplings of 3-pyridyl boronic acids or halides with 2-benzyloxy-4-chloro-3-nitropyridineArgyrios G Arvanitis, Charles R Arnold, Lawrence W Fitzgerald, et al.
Bioorganic & Medicinal Chemistry|August 21, 2003
Pyrazolo-[1,5-a]-1,3,5-triazine corticotropin-releasing factor (CRF) receptor ligandsPaul J Gilligan, Beverly K Folmer, Richard A Hartz, et al.
Bioorganic & Medicinal Chemistry Letters|November 22, 2005
Synthesis and evaluation of 2-anilino-3-phenylsulfonyl-6-methylpyridines as corticotropin-releasing factor1 receptor ligandsRichard A Hartz, Argyrios G Arvanitis, Charles Arnold, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 22, 2003
Pharmacological characterization of a novel nonpeptide antagonist radioligand, (+/-)-N-[2-methyl-4-methoxyphenyl]-1-(1-(methoxymethyl) propyl)-6-methyl-1H-1,2,3-triazolo[4,5-c]pyridin-4-amine ([3H]SN003) for corticotropin-releasing factor1 receptorsGe Zhang, Ning Huang, Yu-Wen Li, et al.
Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
Expert Opinion on Therapeutic Patents|February 11, 2010
Corticotropin-releasing factor receptor antagonistsPaul J Gilligan
Current Topics in Medicinal Chemistry|April 3, 2015
Inhibitors of leucine-rich repeat kinase 2 (LRRK2): progress and promise for the treatment of Parkinson's diseasePaul J Gilligan
Current Opinion in Drug Discovery & Development|September 2, 2004
Corticotropin-releasing factor antagonists: recent advances and exciting prospects for the treatment of human diseasesPaul J Gilligan, Yu-Wen Li
Psychopharmacology|March 15, 2005
Effects of CRF1 receptor antagonists and benzodiazepines in the Morris water maze and delayed non-matching to position testsJohn B Hogan, Donald B Hodges, Snjezana Lelas, et al.
Bioorganic & Medicinal Chemistry Letters|January 30, 2002
Synthesis and evaluation of imidazo[1,5-a]pyrazines as corticotropin releasing hormone receptor ligandsRichard A Hartz, Paul J Gilligan, Kausik K Nanda, et al.
Psychopharmacology|December 11, 2002
The CRF(1) receptor antagonist DMP696 produces anxiolytic effects and inhibits the stress-induced hypothalamic-pituitary-adrenal axis activation without sedation or ataxia in ratsJohn F McElroy, Kathryn A Ward, Kim L Zeller, et al.
Bioorganic & Medicinal Chemistry Letters|December 17, 2002
CRF ligands via Suzuki and Negishi couplings of 3-pyridyl boronic acids or halides with 2-benzyloxy-4-chloro-3-nitropyridineArgyrios G Arvanitis, Charles R Arnold, Lawrence W Fitzgerald, et al.
Bioorganic & Medicinal Chemistry|August 21, 2003
Pyrazolo-[1,5-a]-1,3,5-triazine corticotropin-releasing factor (CRF) receptor ligandsPaul J Gilligan, Beverly K Folmer, Richard A Hartz, et al.
Bioorganic & Medicinal Chemistry Letters|November 22, 2005
Synthesis and evaluation of 2-anilino-3-phenylsulfonyl-6-methylpyridines as corticotropin-releasing factor1 receptor ligandsRichard A Hartz, Argyrios G Arvanitis, Charles Arnold, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 22, 2003
Pharmacological characterization of a novel nonpeptide antagonist radioligand, (+/-)-N-[2-methyl-4-methoxyphenyl]-1-(1-(methoxymethyl) propyl)-6-methyl-1H-1,2,3-triazolo[4,5-c]pyridin-4-amine ([3H]SN003) for corticotropin-releasing factor1 receptorsGe Zhang, Ning Huang, Yu-Wen Li, et al.
Pageof 3